GGrantIndex
← Leaderboards

Sue C Bodine

Oklahoma City Va Medical Center

$5,694,763
Attributed
$9,785,971
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,785,971 · 5
VA$0 · 3

By mechanism

R01$6,655,336 · 3
U01$2,723,651 · 1
R21$406,984 · 1
I01$0 · 3

Top collaborators

Others in their field

Top investigators on “Muscle

Research focus

MuscleMolecularResponsePreventMuscle FormMuscular AtrophyMuscle FunctionAnimal ModelAgingTechnologyMetabolismProteinsBlood Glucose RegulationRattusSignal TransductionAtrophicPharmacologic SubstanceMeasurementPathway InteractionsImmobilizationExerciseDietGrowthChronic Disease

Grant awards (34)

Multidimensional predictive modeling to understand mechanisms of exercise response heterogeneity in older adults$1,470,001
R01 · FY2025 · AG
MuRF1 substrates and mechanisms of skeletal muscle atrophy$181,924
R21 · FY2025 · AR · contact PI
Sarcopenia and recovery from Disuse-Induced Atrophy$0
I01 · FY2025 · VA · contact PI
BCCMA: Recovery of Aged Muscle After Disuse Atrophy (REMEDY): Targeting energetics and proteostasis in recovery from disuse atrophy$0
I01 · FY2025 · VA · contact PI
Multidimensional predictive modeling to understand mechanisms of exercise response heterogeneity in older adults$1,545,208
R01 · FY2024 · AG
MuRF1 substrates and mechanisms of skeletal muscle atrophy$225,060
R21 · FY2024 · AR · contact PI
Sarcopenia and recovery from Disuse-Induced Atrophy$0
I01 · FY2024 · VA · contact PI
MoTrPAC: UC Preclinical Animal Study Site - Supplement$356,597
U01 · FY2023 · AG · contact PI
Sarcopenia and recovery from Disuse-Induced Atrophy$0
I01 · FY2023 · VA · contact PI
MoTrPAC: UC Preclinical Animal Study Site$376,186
U01 · FY2022 · AG · contact PI
MoTrPAC: UC Preclinical Animal Study Site$86,955
U01 · FY2022 · AG · contact PI
Sarcopenia and recovery from Disuse-Induced Atrophy$0
I01 · FY2022 · VA · contact PI
MoTrPAC: UC Preclinical Animal Study Site$460,854
U01 · FY2021 · AG · contact PI
MoTrPAC: UC Preclinical Animal Study Site$460,811
U01 · FY2020 · AG · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$380,433
R01 · FY2020 · AR · contact PI
MoTrPAC: UC Preclinical Animal Study Site$460,238
U01 · FY2019 · AG · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$434,651
R01 · FY2019 · AR · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$471,744
R01 · FY2018 · AR · contact PI
MoTrPAC: UC Preclinical Animal Study Site$454,755
U01 · FY2018 · AG · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$350,151
R01 · FY2017 · AR · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$161,721
R01 · FY2017 · AR · contact PI
MoTrPAC: UC Preclinical Animal Study Site$43,705
U01 · FY2017 · AG · contact PI
MoTrPAC: UC Preclinical Animal Study Site$23,550
U01 · FY2017 · AG · contact PI
The Role of Intramuscular Lipids in Muscle Anabolic Resistance$464,970
R01 · FY2016 · AR · contact PI
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response$0
I01 · FY2015 · VA · contact PI
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response$0
I01 · FY2014 · VA · contact PI
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response$0
I01 · FY2014 · VA · contact PI
Mechanisms Involved in Age-Related Loss of Muscle Mass and Growth Response$0
I01 · FY2012 · VA · contact PI
Glucocorticoid control of gene expression during skeletal muscle atrophy$313,602
R01 · FY2011 · DK
Glucocorticoid control of gene expression during skeletal muscle atrophy$316,770
R01 · FY2010 · DK
Glucocorticoid control of gene expression during skeletal muscle atrophy$10,400
R01 · FY2010 · DK
Glucocorticoid control of gene expression during skeletal muscle atrophy$319,969
R01 · FY2009 · DK
Glucocorticoid control of gene expression during skeletal muscle atrophy$95,747
R01 · FY2009 · DK
Glucocorticoid control of gene expression during skeletal muscle atrophy$319,969
R01 · FY2008 · DK